{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:43:02Z","timestamp":1789846982443,"version":"4.0.1"},"reference-count":42,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NDT"],"DOI":"10.2147\/ndt.s331442","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T15:20:12Z","timestamp":1635348012000},"page":"3229-3244","source":"Crossref","is-referenced-by-count":25,"title":["Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records"],"prefix":"10.2147","volume":"Volume 17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0732-1216","authenticated-orcid":true,"given":"Sheryl","family":"Ker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Balani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8964-7537","authenticated-orcid":true,"given":"Sankha Subhra","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2004-2382","authenticated-orcid":true,"given":"A John","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehreen","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Elchehabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Huffhines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"DeMoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4626-7248","authenticated-orcid":true,"given":"Miguel E","family":"Renter\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joydeep","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","volume":"61","author":"Mark","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2008.976","volume":"301","author":"Chandler","year":"2009","journal-title":"JAMA"},{"key":"ref3","volume-title":"Medications in Recovery: Re-Orientating Drug Dependence Treatment Appendix C \u2013 Opioid Substitution Treatment and Its Effectiveness: Review of the Evidence","year":"2012"},{"key":"ref4","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2019 National Survey on Drug Use and Health: detailed tables. Available from: https:\/\/www.samhsa.gov\/data\/report\/2019-nsduh-detailed-tables. Accessed October 13, 2021."},{"key":"ref5","first-page":"139","volume":"55","author":"Simoens","year":"2005","journal-title":"Br J Gen Pract"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cpr.2013.07.007","volume":"33","author":"Brorson","year":"2013","journal-title":"Clin Psychol Rev"},{"key":"ref7","first-page":"5","volume":"164","author":"Kleber","year":"2007","journal-title":"Am J Psychiatr"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/s0027-9684(15)30175-9","volume":"104","author":"Bonhomme","year":"2012","journal-title":"J Natl Med Assoc"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2165\/11633230-000000000-00000","volume":"32","author":"D\u2019AmoreD\u2019Amore","year":"2012","journal-title":"Clin Drug Investig"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/08897077.2015.1012613","volume":"36","author":"Farmer","year":"2015","journal-title":"Subst Abus"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1080\/14656566.2016.1209486","volume":"17","author":"Maremmani","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"CD002025","DOI":"10.1002\/14651858.CD002025.pub5","volume":"2","author":"Gowing","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1176\/appi.ps.54.9.1199","volume":"54","author":"Gersing","year":"2003","journal-title":"Psychiatr Serv"},{"key":"ref14","unstructured":"Berkeley University of California; 2021. HIPAA PHI: definition of PHI and list of 18 identifiers. UC Berkeley Committee for Protection of Human Subjects. Available from: https:\/\/cphs.berkeley.edu\/hipaa\/hipaa18.html. Accessed October 13, 2021."},{"key":"ref15","unstructured":"Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. In: Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004."},{"key":"ref16","unstructured":"American Psychiatric Association. DSM-III: Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition. Cambridge: Cambridge University Press; 1985."},{"key":"ref17","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-III-R Revised Edition. Cambridge: Cambridge University Press; 1987."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1744-859X-10-2","volume":"10","author":"Aas","year":"2011","journal-title":"Ann Gen Psychiatr"},{"key":"ref19","volume-title":"ECDEU Assessment Manual for Psychopharmacology\u2014Revised","year":"1976"},{"key":"ref20","first-page":"28","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"ref22","first-page":"2825","volume":"12","author":"Pedregosa","year":"2011","journal-title":"JMLR"},{"key":"ref23","unstructured":"Feature importances with a forest of trees [Internet]. Scikit learn; 2020. Available from: https:\/\/scikit-learn.org\/stable\/auto_examples\/ensemble\/plot_forest_importances.html. Accessed April 23, 2021."},{"key":"ref24","first-page":"4765","volume":"30","author":"Lundberg","year":"2017","journal-title":"Adv Neural Inf Process Syst"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1176\/appi.ps.201700363","volume":"69","author":"Manhapra","year":"2018","journal-title":"Psychiatr Serv"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jsat.2019.06.010","volume":"104","author":"Presnall","year":"2019","journal-title":"J Subst Abuse Treat"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/ajad.12553","volume":"26","author":"Manhapra","year":"2017","journal-title":"Am J Addict"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"108317","DOI":"10.1016\/j.drugalcdep.2020.108317","volume":"216","author":"Pizzicato","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/ajad.12921","volume":"28","author":"Huhn","year":"2019","journal-title":"Am J Addict"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/08897077.2017.1356791","volume":"38","author":"Schepis","year":"2017","journal-title":"Subst Abus"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.addbeh.2018.10.046","volume":"90","author":"Ledgerwood","year":"2019","journal-title":"Addict Behav"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","volume":"74","author":"Weinstein","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/acer.13594","volume":"42","author":"Witkiewitz","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/add.15116","volume":"116","author":"Lin","year":"2021","journal-title":"Addiction"},{"key":"ref36","unstructured":"Annual surveillance report of drug-related risks and outcomes \u2014 United States surveillance special report [Internet]. Atlanta: Centers for Disease Control and Prevention; 2019. Available from: https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2019-cdc-drug-surveillance-report.pdf. Accessed April 25, 2021."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","volume":"9","author":"Kampman","year":"2015","journal-title":"J Addict Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/10550887.2011.642758","volume":"31","author":"Fareed","year":"2012","journal-title":"J Addict Dis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.drugalcdep.2007.10.017","volume":"94","author":"Leonardi","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"ref40","unstructured":"Lintzeris N, Clark N, Winstock A, et al. National clinical guidelines and procedures for the use of buprenorphine in the maintenance treatment of opioid dependence; 2006. Available from: https:\/\/insight.qld.edu.au\/file\/184\/download. Accessed April 26, 2021."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000494105","volume":"115","author":"DeMauro","year":"2019","journal-title":"Neonatology"},{"key":"ref42","first-page":"238","volume":"36","author":"Puttkammer","year":"2014","journal-title":"Rev Panam Salud Publica"}],"container-title":["Neuropsychiatric Disease and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=75321","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=75321","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T15:20:31Z","timestamp":1635348031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/factors-that-affect-patient-attrition-in-buprenorphine-treatment-for-o-peer-reviewed-fulltext-article-NDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"URL":"https:\/\/doi.org\/10.2147\/ndt.s331442","relation":{},"ISSN":["1178-2021"],"issn-type":[{"value":"1178-2021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}